Moors & Cabot’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $377K | Sell |
|
|||||
|
2025
Q1 | $536K | Buy |
|
|||||
|
2024
Q4 | $559K | Sell |
|
|||||
|
2024
Q3 | $838K | Sell |
|
|||||
|
2024
Q2 | $858K | Sell |
|
|||||
|
2024
Q1 | $834K | Buy |
|
|||||
|
2023
Q4 | $739K | Buy |
|
|||||
|
2023
Q3 | $690K | Buy |
|
|||||
|
2023
Q2 | $572K | Buy |
|
|||||
|
2023
Q1 | $652K | Buy |
|
|||||
|
2022
Q4 | $568K | Sell |
|
|||||
|
2022
Q3 | $548K | Sell |
|
|||||
|
2022
Q2 | $509K | Sell |
|
|||||
|
2022
Q1 | $801K | Sell |
|
|||||
|
2021
Q4 | $750K | Sell |
|
|||||
|
2021
Q3 | $818K | Buy |
|
|||||
|
2021
Q2 | $705K | Buy |
|
|||||
|
2021
Q1 | $585K | Buy |
|
|||||
|
2020
Q4 | $384K | Buy |
|
|||||
|
2020
Q3 | $437K | Buy |
|
|||||
|
2020
Q2 | $433K | Buy |
|
|||||
|
2020
Q1 | $264K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $227K | Buy |
|
|||||
|
2017
Q3 | $217K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $711K | Sell |
|
|||||
|
2015
Q4 | $1.09M | Sell |
|
|||||
|
2015
Q3 | $1.21M | Buy |
|
|||||
|
2015
Q2 | $1.23M | Buy |
|
|||||
|
2015
Q1 | $1.08M | Buy |
|
|||||
|
2014
Q4 | $815K | Sell |
|
|||||
|
2014
Q3 | $730K | Sell |
|
|||||
|
2014
Q2 | $595K | Buy |
|